by ADRIAN FREDERICK MANZ Manz | Aug 26, 2025 | The Doctor's Dose
Eli Lilly’s Orforglipron Hits Target in Diabetes Trial—Oral GLP-1 Battle with Novo Nordisk Heats Up Key Takeaways 10.5% average weight loss in overweight/obese patients with Type 2 diabetes over ~72 weeks on orforglipron; GI side effects broadly in line with...
by ADRIAN FREDERICK MANZ Manz | Aug 26, 2025 | The Doctor's Dose
Tesla Stock Rises: Why Day Traders Should Be Cautious After Gains Tesla stock rises again, notching its third straight day of gains and closing at $351.67—its highest since late May. The move follows a 6.2% surge on Friday after Fed Chair Jerome Powell’s Jackson Hole...
by ADRIAN FREDERICK MANZ Manz | Aug 26, 2025 | The Doctor's Dose
Boeing Stock Pops as Korean Air Doubles Fleet: Why Jet Orders Are Soaring Boeing stock pops again as demand for new aircraft continues to accelerate. On Tuesday, shares of Boeing (BA) rose 3.5% to $234.83 after Korean Air announced a massive 103-plane order that...
by ADRIAN FREDERICK MANZ Manz | Aug 26, 2025 | The Doctor's Dose
Stocks That Moved Today U.S. equities advanced after a dramatic policy headline—President Donald Trump said he fired Fed Governor Lisa Cook—rekindled questions about central bank independence. Beneath the noise, stocks that moved today were propelled by spectrum...
by ADRIAN FREDERICK MANZ Manz | Aug 25, 2025 | The Doctor's Dose
Stocks moving today: Intel, Keurig Dr Pepper, Wayfair, Strategy, Nvidia, Vital Energy The stocks moving today include Intel, Wayfair, Keurig Dr Pepper, Strategy, Nvidia, and Vital Energy. Headlines span government stakes, tariff probes, big acquisitions, Bitcoin...
by ADRIAN FREDERICK MANZ Manz | Aug 25, 2025 | The Doctor's Dose
Palantir CEO Alex Karp stock sale: price impact and a day-trading playbook A new Palantir CEO, Alex Karp, stock sale disclosed via Form 4 shows 409,072 shares sold last week (automatic transactions tied to tax withholding on vested RSUs) at ~$142.46–$157.56. PLTR...
by ADRIAN FREDERICK MANZ Manz | Aug 25, 2025 | The Doctor's Dose
NIO Stock Soars on ES8 Launch (Aug 2025) A cheaper ES8 with Battery‑as‑a‑Service, the new L90, and improving deliveries have investors re‑rating NIO. Here’s what changed—and how to trade it. What’s New · Why It Matters · Delivery Momentum · Rivals & Price War ·...
by ADRIAN FREDERICK MANZ Manz | Aug 25, 2025 | The Doctor's Dose
US stablecoin rules deposit outflows — the fight over a “yield” loophole Bank trade groups want Congress to amend the new GENIUS Act because they say a loophole lets exchanges indirectly pay interest on third-party stablecoins. They argue that this could trigger US...
by ADRIAN FREDERICK MANZ Manz | Aug 25, 2025 | The Doctor's Dose
xAI lawsuit against Apple and OpenAI over ChatGPT–iPhone integration Elon Musk’s xAI filed a federal antitrust complaint in Texas alleging that Apple’s integration of ChatGPT into iPhones and App Store promotion practices unfairly disadvantage rivals like Grok. Apple...
